Loading…
Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome
Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphoryl...
Saved in:
Published in: | International journal of molecular sciences 2020-05, Vol.21 (9), p.3374 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c478t-100c683575853d75a2ac1cc990817593963921b6a8132f4836d54c85c1a258523 |
---|---|
cites | cdi_FETCH-LOGICAL-c478t-100c683575853d75a2ac1cc990817593963921b6a8132f4836d54c85c1a258523 |
container_end_page | |
container_issue | 9 |
container_start_page | 3374 |
container_title | International journal of molecular sciences |
container_volume | 21 |
creator | Garrido-Pérez, Nuria Vela-Sebastián, Ana López-Gallardo, Ester Emperador, Sonia Iglesias, Eldris Meade, Patricia Jiménez-Mallebrera, Cecilia Montoya, Julio Bayona-Bafaluy, M Pilar Ruiz-Pesini, Eduardo |
description | Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphorylation functioning on the cell's secretome, although it could be a promising approach for the identification and pre-selection of potential circulating biomarkers for mitochondrial diseases. Here, we review the insights obtained from secretome studies with regard to oxidative phosphorylation dysfunction, and the biomarkers that appear, so far, to be promising to identify mitochondrial diseases. We propose two new biomarkers to be taken into account in future diagnostic trials. |
doi_str_mv | 10.3390/ijms21093374 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_dbfc72bb67c3425fbb5141c3ea3431bd</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_dbfc72bb67c3425fbb5141c3ea3431bd</doaj_id><sourcerecordid>2403816834</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-100c683575853d75a2ac1cc990817593963921b6a8132f4836d54c85c1a258523</originalsourceid><addsrcrecordid>eNpdkc9PHCEUx4mpUWt782wm6aWHbgUePy9NzGpbE41N2p4JwzAum5lhCzOm-9_LumpWTzzgwyeP90XohOCvABqfhWWfKcEaQLI9dEQYpTOMhXy3Ux-i9zkvMaZAuT5Ah0BBSyHFETq__R8aO4Z7X_1axLxaxLTuyj4O1cU6t9PgHuub2IQ2-FyNC1_NfddVv71Lfoy9_4D2W9tl__FpPUZ_v1_-mf-cXd_-uJqfX88ck2qcEYydUMAlVxwayS21jjinNVZEcg1agKakFlYRoC1TIBrOnOKOWFqeUDhGV1tvE-3SrFLobVqbaIN5PIjpztg0Btd509Stk7SuhXTAKG_rmhNGHHgLDEjdFNe3rWs11b1vnB_GZLtX0tc3Q1iYu3hvJGVCK1UEn58EKf6bfB5NH7Irc7GDj1M2lGHKGBFig356gy7jlIYyqg0FihSGFerLlnIp5px8-9IMwWaTs9nNueCnux94gZ-DhQcXyaJq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2403816834</pqid></control><display><type>article</type><title>Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Garrido-Pérez, Nuria ; Vela-Sebastián, Ana ; López-Gallardo, Ester ; Emperador, Sonia ; Iglesias, Eldris ; Meade, Patricia ; Jiménez-Mallebrera, Cecilia ; Montoya, Julio ; Bayona-Bafaluy, M Pilar ; Ruiz-Pesini, Eduardo</creator><creatorcontrib>Garrido-Pérez, Nuria ; Vela-Sebastián, Ana ; López-Gallardo, Ester ; Emperador, Sonia ; Iglesias, Eldris ; Meade, Patricia ; Jiménez-Mallebrera, Cecilia ; Montoya, Julio ; Bayona-Bafaluy, M Pilar ; Ruiz-Pesini, Eduardo</creatorcontrib><description>Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphorylation functioning on the cell's secretome, although it could be a promising approach for the identification and pre-selection of potential circulating biomarkers for mitochondrial diseases. Here, we review the insights obtained from secretome studies with regard to oxidative phosphorylation dysfunction, and the biomarkers that appear, so far, to be promising to identify mitochondrial diseases. We propose two new biomarkers to be taken into account in future diagnostic trials.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21093374</identifier><identifier>PMID: 32397676</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adenosine triphosphate ; Adipocytes ; Biomarkers ; Biomarkers - metabolism ; Clinical trials ; Cytochrome ; Deoxyribonucleic acid ; Diagnostic systems ; Disease ; DNA ; DNA, Mitochondrial - genetics ; fibroblast growth factor 21 ; Fibroblast Growth Factors - genetics ; Fibroblast Growth Factors - metabolism ; Genetic testing ; Genetic variability ; Genomes ; Growth Differentiation Factor 15 - genetics ; Growth Differentiation Factor 15 - metabolism ; Humans ; Interleukin-6 - metabolism ; Kinases ; Metabolism ; Mitochondria ; mitochondrial diseases ; Mitochondrial Diseases - genetics ; Mitochondrial Diseases - metabolism ; Mitochondrial DNA ; Mutation ; Oxidative Phosphorylation ; oxidative phosphorylation system ; Phosphorylation ; Physiology ; Proteins ; Review ; Roles ; Secretome ; Secretory Pathway - drug effects ; Secretory Pathway - genetics ; Signal transduction ; Stem cells ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>International journal of molecular sciences, 2020-05, Vol.21 (9), p.3374</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-100c683575853d75a2ac1cc990817593963921b6a8132f4836d54c85c1a258523</citedby><cites>FETCH-LOGICAL-c478t-100c683575853d75a2ac1cc990817593963921b6a8132f4836d54c85c1a258523</cites><orcidid>0000-0002-0269-7337 ; 0000-0003-1770-6299</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2403816834/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2403816834?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32397676$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garrido-Pérez, Nuria</creatorcontrib><creatorcontrib>Vela-Sebastián, Ana</creatorcontrib><creatorcontrib>López-Gallardo, Ester</creatorcontrib><creatorcontrib>Emperador, Sonia</creatorcontrib><creatorcontrib>Iglesias, Eldris</creatorcontrib><creatorcontrib>Meade, Patricia</creatorcontrib><creatorcontrib>Jiménez-Mallebrera, Cecilia</creatorcontrib><creatorcontrib>Montoya, Julio</creatorcontrib><creatorcontrib>Bayona-Bafaluy, M Pilar</creatorcontrib><creatorcontrib>Ruiz-Pesini, Eduardo</creatorcontrib><title>Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphorylation functioning on the cell's secretome, although it could be a promising approach for the identification and pre-selection of potential circulating biomarkers for mitochondrial diseases. Here, we review the insights obtained from secretome studies with regard to oxidative phosphorylation dysfunction, and the biomarkers that appear, so far, to be promising to identify mitochondrial diseases. We propose two new biomarkers to be taken into account in future diagnostic trials.</description><subject>Adenosine triphosphate</subject><subject>Adipocytes</subject><subject>Biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Clinical trials</subject><subject>Cytochrome</subject><subject>Deoxyribonucleic acid</subject><subject>Diagnostic systems</subject><subject>Disease</subject><subject>DNA</subject><subject>DNA, Mitochondrial - genetics</subject><subject>fibroblast growth factor 21</subject><subject>Fibroblast Growth Factors - genetics</subject><subject>Fibroblast Growth Factors - metabolism</subject><subject>Genetic testing</subject><subject>Genetic variability</subject><subject>Genomes</subject><subject>Growth Differentiation Factor 15 - genetics</subject><subject>Growth Differentiation Factor 15 - metabolism</subject><subject>Humans</subject><subject>Interleukin-6 - metabolism</subject><subject>Kinases</subject><subject>Metabolism</subject><subject>Mitochondria</subject><subject>mitochondrial diseases</subject><subject>Mitochondrial Diseases - genetics</subject><subject>Mitochondrial Diseases - metabolism</subject><subject>Mitochondrial DNA</subject><subject>Mutation</subject><subject>Oxidative Phosphorylation</subject><subject>oxidative phosphorylation system</subject><subject>Phosphorylation</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Review</subject><subject>Roles</subject><subject>Secretome</subject><subject>Secretory Pathway - drug effects</subject><subject>Secretory Pathway - genetics</subject><subject>Signal transduction</subject><subject>Stem cells</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkc9PHCEUx4mpUWt782wm6aWHbgUePy9NzGpbE41N2p4JwzAum5lhCzOm-9_LumpWTzzgwyeP90XohOCvABqfhWWfKcEaQLI9dEQYpTOMhXy3Ux-i9zkvMaZAuT5Ah0BBSyHFETq__R8aO4Z7X_1axLxaxLTuyj4O1cU6t9PgHuub2IQ2-FyNC1_NfddVv71Lfoy9_4D2W9tl__FpPUZ_v1_-mf-cXd_-uJqfX88ck2qcEYydUMAlVxwayS21jjinNVZEcg1agKakFlYRoC1TIBrOnOKOWFqeUDhGV1tvE-3SrFLobVqbaIN5PIjpztg0Btd509Stk7SuhXTAKG_rmhNGHHgLDEjdFNe3rWs11b1vnB_GZLtX0tc3Q1iYu3hvJGVCK1UEn58EKf6bfB5NH7Irc7GDj1M2lGHKGBFig356gy7jlIYyqg0FihSGFerLlnIp5px8-9IMwWaTs9nNueCnux94gZ-DhQcXyaJq</recordid><startdate>20200510</startdate><enddate>20200510</enddate><creator>Garrido-Pérez, Nuria</creator><creator>Vela-Sebastián, Ana</creator><creator>López-Gallardo, Ester</creator><creator>Emperador, Sonia</creator><creator>Iglesias, Eldris</creator><creator>Meade, Patricia</creator><creator>Jiménez-Mallebrera, Cecilia</creator><creator>Montoya, Julio</creator><creator>Bayona-Bafaluy, M Pilar</creator><creator>Ruiz-Pesini, Eduardo</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0269-7337</orcidid><orcidid>https://orcid.org/0000-0003-1770-6299</orcidid></search><sort><creationdate>20200510</creationdate><title>Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome</title><author>Garrido-Pérez, Nuria ; Vela-Sebastián, Ana ; López-Gallardo, Ester ; Emperador, Sonia ; Iglesias, Eldris ; Meade, Patricia ; Jiménez-Mallebrera, Cecilia ; Montoya, Julio ; Bayona-Bafaluy, M Pilar ; Ruiz-Pesini, Eduardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-100c683575853d75a2ac1cc990817593963921b6a8132f4836d54c85c1a258523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenosine triphosphate</topic><topic>Adipocytes</topic><topic>Biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Clinical trials</topic><topic>Cytochrome</topic><topic>Deoxyribonucleic acid</topic><topic>Diagnostic systems</topic><topic>Disease</topic><topic>DNA</topic><topic>DNA, Mitochondrial - genetics</topic><topic>fibroblast growth factor 21</topic><topic>Fibroblast Growth Factors - genetics</topic><topic>Fibroblast Growth Factors - metabolism</topic><topic>Genetic testing</topic><topic>Genetic variability</topic><topic>Genomes</topic><topic>Growth Differentiation Factor 15 - genetics</topic><topic>Growth Differentiation Factor 15 - metabolism</topic><topic>Humans</topic><topic>Interleukin-6 - metabolism</topic><topic>Kinases</topic><topic>Metabolism</topic><topic>Mitochondria</topic><topic>mitochondrial diseases</topic><topic>Mitochondrial Diseases - genetics</topic><topic>Mitochondrial Diseases - metabolism</topic><topic>Mitochondrial DNA</topic><topic>Mutation</topic><topic>Oxidative Phosphorylation</topic><topic>oxidative phosphorylation system</topic><topic>Phosphorylation</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Review</topic><topic>Roles</topic><topic>Secretome</topic><topic>Secretory Pathway - drug effects</topic><topic>Secretory Pathway - genetics</topic><topic>Signal transduction</topic><topic>Stem cells</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garrido-Pérez, Nuria</creatorcontrib><creatorcontrib>Vela-Sebastián, Ana</creatorcontrib><creatorcontrib>López-Gallardo, Ester</creatorcontrib><creatorcontrib>Emperador, Sonia</creatorcontrib><creatorcontrib>Iglesias, Eldris</creatorcontrib><creatorcontrib>Meade, Patricia</creatorcontrib><creatorcontrib>Jiménez-Mallebrera, Cecilia</creatorcontrib><creatorcontrib>Montoya, Julio</creatorcontrib><creatorcontrib>Bayona-Bafaluy, M Pilar</creatorcontrib><creatorcontrib>Ruiz-Pesini, Eduardo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garrido-Pérez, Nuria</au><au>Vela-Sebastián, Ana</au><au>López-Gallardo, Ester</au><au>Emperador, Sonia</au><au>Iglesias, Eldris</au><au>Meade, Patricia</au><au>Jiménez-Mallebrera, Cecilia</au><au>Montoya, Julio</au><au>Bayona-Bafaluy, M Pilar</au><au>Ruiz-Pesini, Eduardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-05-10</date><risdate>2020</risdate><volume>21</volume><issue>9</issue><spage>3374</spage><pages>3374-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphorylation functioning on the cell's secretome, although it could be a promising approach for the identification and pre-selection of potential circulating biomarkers for mitochondrial diseases. Here, we review the insights obtained from secretome studies with regard to oxidative phosphorylation dysfunction, and the biomarkers that appear, so far, to be promising to identify mitochondrial diseases. We propose two new biomarkers to be taken into account in future diagnostic trials.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32397676</pmid><doi>10.3390/ijms21093374</doi><orcidid>https://orcid.org/0000-0002-0269-7337</orcidid><orcidid>https://orcid.org/0000-0003-1770-6299</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2020-05, Vol.21 (9), p.3374 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_dbfc72bb67c3425fbb5141c3ea3431bd |
source | PMC (PubMed Central); Publicly Available Content (ProQuest) |
subjects | Adenosine triphosphate Adipocytes Biomarkers Biomarkers - metabolism Clinical trials Cytochrome Deoxyribonucleic acid Diagnostic systems Disease DNA DNA, Mitochondrial - genetics fibroblast growth factor 21 Fibroblast Growth Factors - genetics Fibroblast Growth Factors - metabolism Genetic testing Genetic variability Genomes Growth Differentiation Factor 15 - genetics Growth Differentiation Factor 15 - metabolism Humans Interleukin-6 - metabolism Kinases Metabolism Mitochondria mitochondrial diseases Mitochondrial Diseases - genetics Mitochondrial Diseases - metabolism Mitochondrial DNA Mutation Oxidative Phosphorylation oxidative phosphorylation system Phosphorylation Physiology Proteins Review Roles Secretome Secretory Pathway - drug effects Secretory Pathway - genetics Signal transduction Stem cells Vascular Endothelial Growth Factor A - genetics Vascular Endothelial Growth Factor A - metabolism |
title | Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A00%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxidative%20Phosphorylation%20Dysfunction%20Modifies%20the%20Cell%20Secretome&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Garrido-P%C3%A9rez,%20Nuria&rft.date=2020-05-10&rft.volume=21&rft.issue=9&rft.spage=3374&rft.pages=3374-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21093374&rft_dat=%3Cproquest_doaj_%3E2403816834%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-100c683575853d75a2ac1cc990817593963921b6a8132f4836d54c85c1a258523%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2403816834&rft_id=info:pmid/32397676&rfr_iscdi=true |